Automated Author ProfilePerlman, Elizabeth J.
Perlman, Elizabeth J.
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 3.5 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
This collection contains data from the Children’s Oncology Group (COG) Clinical Trial NCT00379340, “Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor, " Study Chair: David Dix, MD. It was sponsored by NCI and performed by the Children's Oncology Group under study number AREN0533. This phase III trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with newly diagnosed stage III or stage IV Favorable Histology Wilms' tumor. Select patient-level clinical data from this trial is available via the following link: https://nctn-data-archive.nci.nih.gov/node/737.
Authors
- Dix, David B. ;
- Seibel, Nita L. ;
- Chi, Yueh-Yun ;
- Khanna, Geetika ;
- Gratias, Eric ;
- Anderson, James R. ;
- Mullen, Elizabeth A. ;
- Geller, James I. ;
- Kalapurakal, John A. ;
- Paulino, Arnold C. ;
- Perlman, Elizabeth J. ;
- Ehrlich, Peter F. ;
- Malogolowkin, Marcio ;
- Gastier-Foster, Julie M. ;
- Wagner, Elizabeth ;
- Grundy, Paul E. ;
- Fernandez, Conrad V. ;
- Dome, Jeffrey S.
This collection contains data from the Children’s Oncology Group (COG) Clinical Trial NCT00352534 NCT00352534, “Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor". Principle Investigator: Conrad Fernandez, MD in Halifax, NS. It was sponsored by NCI and performed by the Children's Oncology Group under study number AREN0532. This phase III trial is studying vincristine, dactinomycin, and doxorubicin with or without radiation therapy or observation only to see how well they work in treating patients undergoing surgery for newly diagnosed stage I, stage II, or stage III Wilms' tumor.
Authors
- Fernandez, Conrad V. ;
- Mullen, Elizabeth A. ;
- Chi, Yueh-Yun ;
- Ehrlich, Peter F. ;
- Perlman, Elizabeth J. ;
- Kalapurakal, John A. ;
- Khanna, Geetika ;
- Paulino, Arnold C. ;
- Hamilton, Thomas E. ;
- Gow, Kenneth W. ;
- Tochner, Zelig ;
- Hoffer, Fredric A. ;
- Withycombe, Janice S. ;
- Shamberger, Robert C. ;
- Kim, Yeonil ;
- Geller, James I. ;
- Anderson, James R. ;
- Grundy, Paul E. ;
- Dome, Jeffrey S.